Differential vulnerability of the dentate gyrus to tauopathies in dementias.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
03 01 2023
Historique:
received: 21 11 2022
accepted: 23 11 2022
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 6 1 2023
Statut: epublish

Résumé

The dentate gyrus (DG), a key hippocampal subregion in memory processing, generally resists phosphorylated tau accumulation in the amnestic dementia of the Alzheimer's type due to Alzheimer's disease (DAT-AD), but less is known about the susceptibility of the DG to other tauopathies. Here, we report stereologic densities of total DG neurons and tau inclusions in thirty-two brains of human participants with autopsy-confirmed tauopathies with distinct isoform profiles-3R Pick's disease (PiD, N = 8), 4R corticobasal degeneration (CBD, N = 8), 4R progressive supranuclear palsy (PSP, N = 8), and 3/4R AD (N = 8). All participants were diagnosed during life with primary progressive aphasia (PPA), an aphasic clinical dementia syndrome characterized by progressive deterioration of language abilities with spared non-language cognitive abilities in early stages, except for five patients with DAT-AD as a comparison group. 51% of total participants were female. All specimens were stained immunohistochemically with AT8 to visualize tau pathology, and PPA cases were stained for Nissl substance to visualize neurons. Unbiased stereological analysis was performed in granule and hilar DG cells, and inclusion-to-neuron ratios were calculated. In the PPA group, PiD had highest mean total (granule + hilar) densities of DG tau pathology (p < 0.001), followed by CBD, AD, then PSP. PPA-AD cases showed more inclusions in hilar cells compared to granule cells, while the opposite was true in PiD and CBD. Inclusion-to-neuron ratios revealed, on average, 33% of all DG neurons in PiD cases contained a tau inclusion, compared to ~ 7% in CBD, 2% in AD, and 0.4% in PSP. There was no significant difference between DAT-AD and PPA-AD pathologic tau burden, suggesting that differences in DG burden are not specific to clinical phenotype. We conclude that the DG is differentially vulnerable to pathologic tau accumulation, raising intriguing questions about the structural integrity and functional significance of hippocampal circuits in neurodegenerative dementias.

Identifiants

pubmed: 36597124
doi: 10.1186/s40478-022-01485-7
pii: 10.1186/s40478-022-01485-7
pmc: PMC9811688
doi:

Substances chimiques

tau Proteins 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1

Subventions

Organisme : NIA NIH HHS
ID : R01 AG056258
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC008552
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072977
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062566
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : K08 AG065463
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS075075
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS047987
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085770
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG077444
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Neurobiol Dis. 2007 Mar;25(3):561-70
pubmed: 17174556
Prog Brain Res. 1990;83:445-57
pubmed: 2392569
J Physiol Anthropol. 2020 Jul 2;39(1):15
pubmed: 32616078
Ann Neurol. 2016 Feb;79(2):272-87
pubmed: 26583316
Neurology. 1998 Dec;51(6):1546-54
pubmed: 9855500
Neurology. 2016 Feb 16;86(7):627-36
pubmed: 26791154
Arch Neurol. 1996 Oct;53(10):1072-8
pubmed: 8859072
Front Neural Circuits. 2014 Sep 10;8:107
pubmed: 25309334
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
J Comp Neurol. 2003 Jan 6;455(2):249-59
pubmed: 12454989
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5832-6
pubmed: 2377621
Prog Brain Res. 2002;136:467-86
pubmed: 12143403
N Engl J Med. 2003 Oct 16;349(16):1535-42
pubmed: 14561797
Brain. 2018 Jan 1;141(1):288-301
pubmed: 29228211
Nat Rev Neurol. 2010 Feb;6(2):88-97
pubmed: 20139998
Neurology. 2001 Jun;56(11 Suppl 4):S16-20
pubmed: 11402145
Hippocampus. 2007;17(2):98-102
pubmed: 17183532
Brain. 2019 Jun 1;142(6):1701-1722
pubmed: 31135048
Nat Genet. 2011 Jun 19;43(7):699-705
pubmed: 21685912
Front Neuroanat. 2019 Dec 19;13:99
pubmed: 31920568
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
pubmed: 7566337
Neurology. 2010 May 18;74(20):1607-10
pubmed: 20479359
Brain. 2014 Apr;137(Pt 4):1176-92
pubmed: 24574501
J Neurosci. 2012 Aug 1;32(31):10574-86
pubmed: 22855807
Science. 1988 Jan 15;239(4837):285-8
pubmed: 3122323
Neurosci Lett. 2004 Apr 15;359(3):151-4
pubmed: 15050686
Neuroscience. 1989;31(3):571-91
pubmed: 2687721
Trends Neurosci. 2010 Mar;33(3):153-61
pubmed: 20071039
Neurobiol Aging. 2012 Apr;33(4):744-52
pubmed: 20580129
Behav Brain Res. 2010 Dec 31;215(2):275-91
pubmed: 20633579
Ann Neurol. 2006 Jan;59(1):156-65
pubmed: 16374817
Neuron. 1989 Oct;3(4):519-26
pubmed: 2484340
Ann Neurol. 1982 Jun;11(6):592-8
pubmed: 7114808
Acta Neuropathol. 2001 May;101(5):518-24
pubmed: 11484824
Brain Pathol. 2021 Jan;31(1):189-204
pubmed: 33010092
Neurology. 2001 Jun 26;56(12):1702-6
pubmed: 11425937
Brain. 2022 Apr 29;145(3):1069-1078
pubmed: 34919645
Brain. 2016 May;139(Pt 5):1551-67
pubmed: 26962052
Brain. 2012 May;135(Pt 5):1554-65
pubmed: 22522938
Nat Rev Neurosci. 2020 Mar;21(3):153-168
pubmed: 32042144
Brain. 2009 May;132(Pt 5):1324-34
pubmed: 19321462
Prog Brain Res. 2007;163:723-40
pubmed: 17765747
Acta Neuropathol. 2006 Oct;112(4):439-49
pubmed: 16802167
Hippocampus. 2001;11(6):626-36
pubmed: 11811656
Front Aging Neurosci. 2019 Dec 04;11:327
pubmed: 31866851
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Neurology. 2021 Feb 9;96(6):e916-e925
pubmed: 33441454
Ann Neurol. 2008 Jun;63(6):709-19
pubmed: 18412267
Behav Brain Res. 2012 Jun 15;232(1):269-77
pubmed: 22546523
J Alzheimers Dis. 2012;29(4):921-30
pubmed: 22337826
J Mol Neurosci. 2011 Nov;45(3):384-9
pubmed: 21720721
Neurology. 2018 Jan 30;90(5):e396-e403
pubmed: 29305438

Auteurs

Allegra Kawles (A)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Psychiatry & Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Grace Minogue (G)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.

Antonia Zouridakis (A)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.

Rachel Keszycki (R)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Psychiatry & Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Nathan Gill (N)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Caren Nassif (C)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.

Christina Coventry (C)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.

Hui Zhang (H)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Emily Rogalski (E)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Psychiatry & Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Margaret E Flanagan (ME)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Rudolph Castellani (R)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Eileen H Bigio (EH)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

M Marsel Mesulam (MM)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Changiz Geula (C)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA.
Department of Cell and Developmental Biology, Northwestern University Feinberg School of Medicine, Chicago, USA.

Tamar Gefen (T)

Mesulam Center for Cognitive Neurology & Alzheimer's Disease, Northwestern University Feinberg School of Medicine, 300 E. Superior Street, Tarry Building, 8th Floor, Chicago, IL, 60611, USA. tamar.gefen@northwestern.edu.
Department of Psychiatry & Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. tamar.gefen@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH